The Pulmonary Fibrosis Treatment Market To Surpass Covid-19 Cringe From 2029 Onw

Posted by Ashish on January 15th, 2021

Globally, increasing diagnosis rate for the pulmonary fibrosis is expected to drive the growth of the pulmonary fibrosis treatment market. According to the latest research by the company, the global pulmonary fibrosis treatment market is projected to account for a market value of ~US$ 4.4 Bn by the end of 2029. The report also projects significant growth potential for the pulmonary fibrosis treatment market throughout the forecast period.

Increasing diagnosis rate of the pulmonary fibrosis due to enhanced understanding of the disease is the prime driver of the pulmonary fibrosis treatment market. Although the disease understanding and understanding of the associated symptoms has advanced immensely, misdiagnosis still remains as high as 40% in developed regions, potentially hampering the growth of the pulmonary fibrosis treatment market.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/30070

Company Profiles:

  • Genentech, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Alkem Laboratories Ltd.
  • Alniche Life Sciences Pvt Ltd
  • MHS Pharmaceuticals
  • Torrent Pharmaceuticals Ltd
  • Anthem Biopharma Pvt Ltd
  • Panacea Biotec
  • Zydus Healthcare Ltd
  • Nuper Therapeutics
  • Fresenius Kabi India Pvt Ltd.

Like it? Share it!


Ashish

About the Author

Ashish
Joined: September 12th, 2019
Articles Posted: 582

More by this author